ArticleClinical rheumatology2026

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Stefano Di Donato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.